These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8658640)

  • 1. Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report.
    Kita Y; Iwaki Y; Noguchi K; Tzakis AG; Todo S; Fung JJ; Starzl TE
    Transplant Proc; 1996 Jun; 28(3):1237-40. PubMed ID: 8658640
    [No Abstract]   [Full Text] [Related]  

  • 2. Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts.
    Kita Y; Iwaki Y; Noguchi K; Griffith BP; Tzakis AG; Todo S; Fung JJ; Starzl TE
    Transplant Proc; 1996 Jun; 28(3):1229-34. PubMed ID: 8658638
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum levels of interleukin-6, tumor necrosis factor-alpha, and interleukin-2 in rejecting human small bowel allografts.
    Noguchi K; Yoshida Y; Yagihashi A; Kita Y; Takenaka T; Terasawa K; Hayashi S; Konno A; Kobayashi M; Nakamura K
    Transplant Proc; 1992 Jun; 24(3):1152. PubMed ID: 1604565
    [No Abstract]   [Full Text] [Related]  

  • 4. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.
    George JF; Kirklin JK; Naftel DC; Bourge RC; White-Williams C; McGiffin DC; Savunen T; Everson MP
    J Heart Lung Transplant; 1997 Oct; 16(10):1046-53. PubMed ID: 9361247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of plasma levels of tumour necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy.
    Abdallah AN; Billes MA; Attia Y; Doutremepuich C; Cassaigne A; Iron A
    Eur Heart J; 1997 Jun; 18(6):1024-9. PubMed ID: 9183597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunological aspects of liver allograft rejection.
    Schlitt HJ
    Transplant Proc; 1996 Feb; 28(1):514-6. PubMed ID: 8644333
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring of plasma endothelin in relation to Doppler signal in human liver transplantation.
    Rudy T; Hartwig T; Fritschka E; Erhard J; Eigler FW
    Transplant Proc; 1993 Aug; 25(4):2658-61. PubMed ID: 8356712
    [No Abstract]   [Full Text] [Related]  

  • 8. Serial ultrasensitive CRP measurements may be useful in rejection diagnosis after kidney transplantation.
    Oyen O; Wergeland R; Bentdal O; Hartmann A; Brekke IB; Stokke O
    Transplant Proc; 2001 Jun; 33(4):2481-3. PubMed ID: 11406220
    [No Abstract]   [Full Text] [Related]  

  • 9. Rejection of human liver allografts: immuno-histopathologic relationship and direct allorecognition of donor antigens by T lymphocytes.
    Arvieux C; Drouet C; Pasquier D; Zarski JP; Barnoud D; Granger P; Delannoy P; Letoublon C
    Transplant Proc; 1996 Oct; 28(5):2849-50. PubMed ID: 8908097
    [No Abstract]   [Full Text] [Related]  

  • 10. An experimental model of rat liver allograft rejection monitored with FNAB.
    Martelius T; Mäkisalo H; Höckerstedt K; Taskinen E; Lautenschlager I
    Transplant Proc; 1995 Dec; 27(6):3550-1. PubMed ID: 8540097
    [No Abstract]   [Full Text] [Related]  

  • 11. Histopathology of hepatic allograft rejection after living-related liver transplantation.
    Sageshima J; Fuchinoue S; Hashimoto E; Koike T; Abe M; Nakajima I; Tanaka K; Agishi T
    Transplant Proc; 1998 Nov; 30(7):3214-5. PubMed ID: 9838421
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience in therapy of chronic liver allograft rejection.
    Charco R; Ruiz C; Allende E; Balsells J; Lazaro JL; Murio E; Bilbao I; Gifre E; Margarit C
    Transplant Proc; 1995 Aug; 27(4):2293-4. PubMed ID: 7652811
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of IL-2, IL-2R, IL-6, and TNF-alpha as a diagnostic test of acute rejection after renal transplantation.
    Cho WH; Kim HT; Sohn CY; Park CH; Park SB; Kim HC
    Transplant Proc; 1998 Nov; 30(7):2967-9. PubMed ID: 9838310
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic value of eosinophils for therapeutic response in severe acute hepatic allograft rejection.
    Ben-Ari Z; Dhillon AP; Garwood L; Rolles K; Davidson B; Burroughs AK
    Transplant Proc; 1996 Dec; 28(6):3624-8. PubMed ID: 8962399
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal anti-tumor necrosis factor-alpha antibody suppresses rejection, but enhances infectious complications in rat liver allograft recipients.
    Shiraishi M; Shaked A; Yasunaga C; Hasuike Y; Imagawa DK; Busuttil RW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):128-9. PubMed ID: 8438250
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum and urine IL-6 and TNF-alpha in renal transplant recipients with graft dysfunction.
    Newstead CG; Lamb WR; Brenchley PE; Short CD
    Transplantation; 1993 Oct; 56(4):831-5. PubMed ID: 8212202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory acute rejection in a living related liver transplantation.
    Noritomi T; Sugawara Y; Kaneko J; Matsui Y; Makuuchi M
    Hepatogastroenterology; 2003; 50(54):2192-3. PubMed ID: 14696495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-allograft production and systemic release of tumor necrosis factor-alpha: detection upon reperfusion.
    Kalb TH; Walter M; Mayer L; Acarli K; Fukuzawa K; Schwanz ME; Miller CM
    Transplant Proc; 1993 Apr; 25(2):1817-8. PubMed ID: 8470177
    [No Abstract]   [Full Text] [Related]  

  • 19. Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression.
    Gaweco AS; Otto G; Otto HF; Geisse T; Hofmann WJ
    Transplant Proc; 1994 Dec; 26(6):3111-3. PubMed ID: 7527948
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of tumor necrosis factor in allograft rejection.
    Zhu ZG; Asahara T; Yahata H; Ono E; Marubayashi S; Watanabe H; Fukuda Y; Dohi K
    Hiroshima J Med Sci; 1993 Dec; 42(4):129-35. PubMed ID: 8014063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.